⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10973310 | 0.81 | — | — | |
| SCHEMBL653873 | 0.78 | ALDH1A1 (0.40) | — | |
| SCHEMBL7024228 | 0.78 | — | — | |
| SCHEMBL11119392 | 0.76 | — | — | |
| SCHEMBL10436518 | 0.76 | — | — | |
| Ethylene SCHEMBL9565670 | 0.75 | — | — | |
| SCHEMBL3127800 | 0.73 | — | — | |
| SCHEMBL9111058 | 0.72 | ENPEP (0.38) | — | |
| SCHEMBL11810443 | 0.72 | ENPEP (0.38) | — | |
| SCHEMBL181418 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7960180-B2 | Water treatment; preventing gastrointestinal disorders; eluting for infectious agent identification; low cost; filtering large volumes in field operations | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2011-06-14 | — | — | US | claimed |
| US-20080237134-A1 | METHODS AND APPARATUS TO CAPTURE AND RELEASE MICROBE PARTICLES USING AMINO-FUNCTIONALIZED SILICA | SCIENTIFIC METHODS, INC. | 2008-10-02 | — | — | US | claimed |
| WO-2023186269-A1 | CROSS-LINKABLE COMPOSITIONS ON THE BASIS OF ORGANOSILICON COMPOUNDS | WACKER CHEMIE AG (DE) | 2023-10-05 | — | — | WO | disclosed |
| CN-112313317-A | Purification of edible oils and fats with amino-functionalized silica adsorbent materials | 美国达拉斯集团公司 | 2021-02-02 | — | — | CN | disclosed |
| US-10752977-B2 | Palladium separating agent, method for producing same and use of same | TOSOH CORPORATION (JP) | 2020-08-25 | — | — | US | disclosed |
| EP-2755991-B1 | METHOD FOR PREPARATION OF BETULINIC ACID | STORA ENSO OYJ (FI) | 2018-05-16 | — | — | EP | disclosed |
| EP-2765208-B1 | PALLADIUM SEPARATING AGENT, METHOD FOR PRODUCING SAME AND USE OF SAME | TOSOH CORP (JP) | 2017-02-01 | — | — | EP | disclosed |
| US-8852512-B2 | Monitor and a method for measuring oxygen concentration | AIRBUS OPERATIONS LTD (GB) | 2014-10-07 | — | — | US | disclosed |
| US-20140248198-A1 | PALLADIUM SEPARATING AGENT, METHOD FOR PRODUCING SAME AND USE OF SAME | TOSOH CORPORATION (JP) | 2014-09-04 | — | — | US | disclosed |
| EP-2765208-A1 | PALLADIUM SEPARATING AGENT, METHOD FOR PRODUCING SAME AND USE OF SAME | Tosoh Corporation (JP) | 2014-08-13 | — | — | EP | disclosed |
| EP-2755991-A1 | METHOD FOR PREPARATION OF BETULINIC ACID | Stora Enso Oyj (FI) | 2014-07-23 | — | — | EP | disclosed |
| US-20100018119-A1 | MONITOR AND A METHOD FOR MEASURING OXYGEN CONCENTRATION | AIRBUS OPERATIONS LTD (GB) | 2010-01-28 | — | — | US | disclosed |
| US-7579349-B2 | 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer | ASTRAZENECA AB (SE) | 2009-08-25 | — | — | US | disclosed |
| EP-1678169-B1 | 4-(PYRAZOL-3-YLAMINO)PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER | ASTRAZENECA AB (SE) | 2009-07-22 | — | — | EP | disclosed |
| EP-1855641-A1 | DYE CARRIER MASS | Wella Aktiengesellschaft (DE) | 2007-11-21 | — | — | EP | disclosed |
| US-20070037888-A1 | anticarcinogenic agent 5-Chloro-2-{2-[3-(pyrid-2-yl)isoxazol-5-yl]pyrrolidin-1-yl}-4-(5-methyl-1H-pyrazol-3-ylamino)pyrimidine; chemical synthesis; use in modulating insulin-like growth factor 1 receptor activity | ASTRAZENECA AB (SE) | 2007-02-15 | — | — | US | disclosed |
| CN-1894243-A | 4- (pyrazol-3-ylamino) pyrimidine derivatives for the treatment of cancer | ASTRAZENECA AB (SE) | 2007-01-10 | — | — | CN | disclosed |
| WO-2006088973-A1 | DYE CARRIER MASS | THE PROCTER & GAMBLE COMPANY (US) | 2006-08-24 | — | — | WO | disclosed |
| EP-1678169-A1 | 4-(PYRAZOL-3-YLAMINO)PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER | Astrazeneca AB (SE) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005040159-A1 | 4-(PYRAZOL-3-YLAMINO) PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER | ASTRAZENECA AB (SE) | 2005-05-06 | — | — | WO | disclosed |